News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media News & Stories
In the Media, Staff/Faculty Update
Thaker named Chief of Gynecologic Oncology
Nationally recognized clinical trials expert, also known for outstanding patient care Premal H. Thaker, MD, MS, a physician-scientist recognized for her expertise in conducting clinical trials, authoring numerous medical and scientific publications and outstanding patient care, has been named chief of the Division of Gynecologic Oncology at WashU Medicine. In this role, she oversees a […]
In the Media, Staff/Faculty Update
De Los Santos, Hugo recognized by ASTRO
Two WashU Medicine professors of radiation oncology – Jennifer De Los Santos, MD, and Geoffrey Hugo, PhD – have been named fellows of the American Society for Radiation Oncology (ASTRO). ASTRO counts 10,000 members worldwide, including physicians, physicists and cancer biologists, whose work advances care, education, professional development and research in the radiation oncology field. Only 541 of ASTRO’s […]
Clinical, In the Media, Research
Siteman recruiting participants for multi-cancer detection tests
National study aims to detect disease before symptoms appear Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is recruiting participants for a national study of a new type of blood test aimed at detecting several types of cancer before symptoms appear. The tests could identify the presence of ovarian, pancreatic, bladder and other cancers […]
In the Media
Siteman named among top U.S. cancer centers
Newsweek rankings note the strength of breast, prostate, lung and colorectal cancer and leukemia programs Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine has been ranked No. 13 of cancer centers nationwide by Newsweek. The recognition — part of the news magazine’s listing of America’s Best Hospitals for Specialized Care 2025 — makes Siteman […]
In the Media, Research
AI-driven blood test could aid earlier detection of brain cancer
WashU Medicine physician-researchers at The Brain Tumor Center at Siteman Cancer Center have co-developed an innovative approach that uses artificial intelligence (AI) to detect brain cancer, potentially leading to earlier diagnoses. Siteman is based at Barnes-Jewish Hospital and WashU Medicine. The process incorporates a noninvasive blood test and machine learning that analyzes the blood sample […]
In the Media
The Brain Tumor Center at Siteman announces associate directors
Huang is promoted, and Chheda joins the leadership team of the multidisciplinary practice The Brain Tumor Center at Siteman Cancer Center, a multidisciplinary practice of physicians and scientists, has named two board-certified WashU Medicine faculty members as associate directors. They are: “We are proud to announce Dr. Huang’s new leadership role, which reflects his deep […]
In the Media, Research
Innovative immunotherapy shows promise against aggressive T cell cancers
WashU startup’s “off-the-shelf” CAR-T cell therapy evaluated in international clinical trial A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by WashU Medicine researchers at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine. […]
In the Media, Staff/Faculty Update
Cornelius receives research achievement award
American Skin Association recognizes her work in public policy, education Lynn Cornelius, MD, the Winfred and Emma Showman Professor of Dermatology and chief of the Division of Dermatology at WashU Medicine, has been honored with the 2025 Research Achievement Award in Public Policy and Education from the American Skin Association. The award, given May 9 […]
In the Media
Immunotherapy improves survival of patients with locally advanced head and neck cancer
Approved drug that revolutionized melanoma treatment may change the standard of care for yet another cancer type An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis and Dana-Farber Brigham Cancer Center shows that patients with certain locally advanced head and neck cancers benefited from the addition of the […]
In the Media